Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies - Gertner-Dardenne, Julie; Bonnafous, Cecile; Bezombes, Christine; Capietto, Aude-Hélène; Scaglione, Virginie; Ingoure, Sophie; Cendron, Delphine; Gross, Emilie; Lepage, Jean-François; Quillet-Mary, Anne; Ysebaert, Loîc; Laurent, Guy; et al. (Blood, 2009)
Keywords: Adult; Animals; Antibodies, Monoclonal - administration & dosage; Antibodies, Monoclonal - chemistry; Antibodies, Monoclonal - pharmacology; Antibodies, Monoclonal, Murine-Derived; Antibody-Dependent Cell Cytotoxicity - drug effects; Antineoplastic Combined Chemotherapy Protocols - chemistry; Antineoplastic Combined Chemotherapy Protocols - pharmacology; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; B-Lymphocytes - immunology; B-Lymphocytes - metabolism; Biological and medical sciences; Cancer; Cells, Cultured; Diphosphates - administration & dosage; Diphosphates - immunology; Diphosphates - pharmacology; Drug Screening Assays, Antitumor; Female; Hematologic and hematopoietic diseases; Humans; Immunology; Interleukin-2 - administration & dosage; Leukemia, Lymphocytic, Chronic, B-Cell - blood; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy; Leukemia, Lymphocytic, Chronic, B-Cell - immunology; Life Sciences; Macaca fascicularis; Male; Medical sciences; Phosphates - immunology; Receptors, Antigen, T-Cell, gamma-delta - metabolism; Rituximab; T-Lymphocytes - immunology; T-Lymphocytes - metabolism; Up-Regulation - drug effects; Up-Regulation - immunology; Treatment; Hematology; Antibody; Antibody-dependent cell cytotoxicity